"Clinically predictive preclinical efficacy testing services at your disposal"


Jussi Halleen - CEO, Pharmatest Services

Current news

PHARMATEST EVENTS DURING 2018

January 16, 2018

Pharmatest has announced the list of events where staff of Pharmatest will attend during 2018. The first events will be an educational seminar held in San Diego on Jan 23 in an event organized by…

Read More »

Pharmatest credits Bruker for SkyScan 1276 in vivo micro-CT

November 24, 2017

Bruker installed its first SkyScan 1276 High-Resolution and Fast In Vivo Desktop Micro-Computed Tomography (micro-CT) in premises of Pharmatest on February 2017. After 9 months of experience…

Read More »

Radiotherapy expertise in Pharmatest

November 2, 2017

Pharmatest Services has successfully worked with radioactive compounds for almost a decade. Recent scientific publication in collaboration with Bayer shows an example of the strong expertise of…

Read More »

Pharmatest attends ASBMR Annual Meeting in Denver

August 28, 2017

Pharmatest Services attends Annual Meeting of The American Society for Bone and Mineral Research (ASBMR) that will be held in Denver, CO, USA on September 8 – 11, 2017. Pharmatest attends the event…

Read More »

Educational seminar in Boston highlights significance of bone metastases

August 24, 2017

Pharmatest Services LLC arranges an educational seminar titled “Significance of Bone Metastases and Targeting Tumor, Bone and Immune System” in hotel Boston Marriott Copley Place in Boston, MA, on…

Read More »

Pharmatest has established a subsidiary in USA

June 7, 2017

Pharmatest Services LLC is a US based CRO operating in Massachusetts, where it offers preclinical efficacy services in oncology and skeletal diseases. The company is a fully owned subsidiary of…

Read More »

Pharmatest launches the first novel humanized mouse model of tumor growth in bone suitable for testing immunotherapies

May 16, 2017

Pharmatest Services Ltd has developed in collaboration with Taconic Biosciences a novel humanized mouse model of tumor growth in bone that can be used for testing immunotherapies. Testing compound…

Read More »

Pharmatest attends AACR Annual Meeting in Washington

March 13, 2017

Pharmatest Services Ltd attends Annual Meeting of American Association for Cancer Research (AACR) held in Washington, D.C., USA on April 1 – 5, 2017. Pharmatest attends the event with a booth (#3538)…

Read More »

PHARMATEST JOINS BIOCOM AND SCIENCE EXCHANGE IN CALIFORNIA

February 22, 2017

Pharmatest Services Ltd has joined two California-based organizations Biocom and Science Exchange. Biocom is the largest life science organization in California, and Science Exchange is the leading…

Read More »